Company news

Ventripoint Diagnostics Ltd. (TSXV:VPT) news

Ventripoint Diagnostics Ltd. news releases on 6ix. Latest, Oct 6, 2026: Ventripoint Provides Corporate Update and Announces Shareholder Videoconference Call

Ventripoint Diagnostics Ltd. (TSXV:VPT) news

Press releases & updates

Ventripoint Provides Corporate Update and Announces Shareholder Videoconference Call

Ventripoint Announces Successful Completion of Annual Quality and Regulatory Audits

Ventripoint Closes First Tranche of Private Placement Financing and Engages Strategic Advisors to Accelerate Commercialization of VMS+(TM) Technology

UniDoc Health Signs MOU with Ventripoint Diagnostics to Evaluate Remote Cardiac Assessment and Screening Platform

Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging

Ventripoint Diagnostics Announces Cancellation and Re-Grant of Options, Grant of Annual Incentive Options and Private Placement

UniDoc Health and Ventripoint Diagnostics Sign MOU to Evaluate Scalable Remote Cardiac Assessment and Screening Platform

Ventripoint Strengthens Board with Appointment of MedTech Executive and Commercialization Leader Dr. Philip Toleikis

Ventripoint Engages More Capital Ltd.

Ventripoint Diagnostics' VMS+ Technology Selected for World-First AI Cardiac Monitoring Study in Breast Cancer Patients

Ventripoint and Ollie Hinkle Heart Foundation Partner to Expand Access to AI-Powered Heart Imaging for Children Living with Heart Disease

16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap

Ventripoint Diagnostics Announces Support for the Global Congenital Heart Disease Alliance

Ventripoint Announces Adoption of Semi-Annual Reporting (SAR)

Ventripoint Provides Videoconference Link to Annual General Meeting and Corporate Update

Ventripoint Announces Closing of $308,030 Non-Brokered Units Private Placement

Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts

A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in Medtech

The $59B Quiet Shift Reshaping How Patients Access Care

Ventripoint to Exhibit at the 59th Annual Meeting of the Association for European Paediatric and Congenital Cardiology

Why Medtech Giants Are Quietly Paying Up for AI Diagnostics

Ventripoint's VMS+ (TM) 4.0 Submitted for Regulatory Approval in China by Lishman Global Inc.

Ventripoint Issue Shares for Payment of Debenture Interest

Ventripoint's VMS+(TM) 4.0 Recognized with Gold Edison Award, Validating Leadership and Future Potential

The Quiet Shift Replacing Million-Dollar Heart Scanners With Software

Ventripoint Diagnostics Announces Collaboration with the Health Division of the Montecristo Group

MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value

How Decentralized AI is Unlocking Value in Cardiac Diagnostics

Ventripoint Partners with First Light Health to Bring AI-Powered Cardiac Diagnostics to Indigenous and Remote Communities

Ventripoint Issues Shares for Payment of Debenture Interest and Reports on Debenture Conversions

Hospital Networks Turn to AI-Enhanced Cardiac Imaging to Cut Costs and Improve Outcomes

Ventripoint Diagnostics Ltd. Signs Commercial Agreement with LG Consulting Solutions to Support VMS+ Deployment in Northern California

CEO.CA's Inside the Boardroom: Why Ventripoint is the Most Profitable "Bolt-On" Solution for Modern Hospitals

THE SIGNAL ARCHITECTURE: 5 Stocks Calibrating the 2026 Infrastructure Cycle

Ventripoint Provides Corporate Update and Announces Shareholder Video Conference Call

THE SOVEREIGNTY DOCTRINE: 5 Assets Locking Down the 2026 Survival Cycle

AI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural Shift

Ventripoint Issues Shares for Debt Settlement and Awards Option Grants

AI Medical Imaging Revolution: Software-Native Tech Disrupts $45B Market

Ventripoint Announces Closing of Non-Brokered Units Private Placement

Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic

AI Diagnostics: The End of the High-Cost Imaging Era

THE SCARCITY DOCTRINE: 5 Assets Securing the 2026 Material Cycle

Ventripoint Issues Shares for Payment of Debenture Interest

Ventripoint Doubles the Size of Private Placement Due to Strong Investor Demand

Ventripoint Announces Non-Brokered Units Private Placement

Ventripoint Diagnostics Announces Collaboration with Summit Sciences

Ventripoint to Issue Shares for Payment of Debenture Interest

THE FOUNDATION TRADE: 5 Assets Anchoring the Next Industrial Cycle

THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis